Trevor Batty, DO
Dermatology · Chubbuck, IDNPI 1558756106
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 33.0% of the total.
Across 286 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$753
- Johnson & Johnson$474
- Regeneron Healthcare Solutions, Inc.$235
- Lilly USA, LLC$208
- LEO Pharma Inc.$201
- plus $949 from 20 others
What the payments were for
- Food & beverage$3,90293%
- Education$3047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 85 | $1,386 |
| Novartis | 91 | $753 |
| Johnson & Johnson | 25 | $474 |
| Regeneron Healthcare Solutions, Inc. | 9 | $235 |
| Lilly USA, LLC | 12 | $208 |
| LEO Pharma Inc. | 10 | $201 |
| UCB, Inc. | 6 | $107 |
| VYNE Pharmaceuticals Inc. | 2 | $107 |
| Arcutis Biotherapeutics, Inc. | 7 | $105 |
| E.r. Squibb & Sons, L.L.C. | 5 | $86 |
| Biofrontera Inc. | 4 | $77 |
| Galderma Laboratories, L.p. | 5 | $73 |
| Pfizer | 4 | $60 |
| Boehringer Ingelheim | 2 | $46 |
| Dermavant Sciences, Inc. | 2 | $39 |
| Incyte Corporation | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Sanofi | 2 | $27 |
| Prugen, Inc. Pharmaceuticals | 1 | $26 |
| Sandoz | 1 | $25 |
| Amgen | 2 | $25 |
| Organon | 3 | $22 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Merz North America, Inc. | 1 | $12 |
How this compares
$4,206 in reported general payments places this provider in the 75th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $217,806 |
| Bimzelx AutoinjectorBimekizumab-Bkzx | 12 | $174,117 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $78,646 |
| Dupixent PenDupilumab | 19 | $69,100 |
| SotyktuDeucravacitinib | 11 | $64,090 |
| Fluorouracil | 59 | $6,854 |
| Clobetasol Propionate | 128 | $4,408 |
| Metronidazole | 68 | $4,034 |
| Ketoconazole | 189 | $3,010 |
| Fluocinonide | 55 | $2,743 |
| Imiquimod | 57 | $2,371 |
| Clindamycin Phosphate | 47 | $2,282 |
| Triamcinolone Acetonide | 207 | $2,254 |
| Tacrolimus | 12 | $1,760 |
| Doxycycline Hyclate | 40 | $966 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Sotyktu | $86 | $64,09011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 52 dermatology providers in Idaho.
Other dermatology in Chubbuck
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
- Ryan OwsleyNampa$9K
- Kelsey FerrellMeridian$6K
- Nicholas BlickenstaffBoise$6K
- Randall BurrMeridian$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.